{"schema_version":"secwatch.filing_event.v1","accession":"0001099219-25-000191","form_type":"8-K","ticker":"MET","cik":"0001099219","company_name":"METLIFE INC","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.338736+00:00","generated_at":"2026-05-17T18:53:24.216302+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MetLife Q2 adjusted EPS $2.02, down 11% YoY; net income $698M; PFOs ex-PRT up 5%","bullets":["Adjusted earnings $1.36B ($2.02 EPS) vs $1.63B ($2.28) in 2Q24, down 16% (11% per share).","Net income $698M ($1.03 EPS) vs $912M ($1.28) in prior year, down 23%.","Adjusted PFOs ex-PRT rose 5% to $12.4B; net investment income +9% to $5.7B; variable investment income fell to $195M pre-tax.","Returned ~$900M to shareholders: $510M buybacks + $382M dividends; holding company cash $5.2B.","Asia sales +9% CC, Latin America adj earnings +15% CC, EMEA +30%; Group Benefits adj PFOs +4%."],"urls":{"canonical":"https://secwatch.observer/filing/0001099219-25-000191","json":"https://secwatch.observer/filing/0001099219-25-000191.json","markdown":"https://secwatch.observer/filing/0001099219-25-000191.md","text":"https://secwatch.observer/filing/0001099219-25-000191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000191/0001099219-25-000191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000191/met-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:53:24.216302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}